RT Journal Article
SR Electronic
T1 Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002582
DO 10.1136/jitc-2021-002582
VO 9
IS 7
A1 Leclercq, Gabrielle
A1 Haegel, Hélène
A1 Schneider, Anneliese
A1 Giusti, Anna Maria
A1 Marrer-Berger, Estelle
A1 Boetsch, Christophe
A1 Walz, Antje-Christine
A1 Pulko, Vesna
A1 Sam, Johannes
A1 Challier, John
A1 Ferlini, Cristiano
A1 Odermatt, Alex
A1 Umaña, Pablo
A1 Bacac, Marina
A1 Klein, Christian
YR 2021
UL http://jitc.bmj.com/content/9/7/e002582.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.